Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 7,514,092
- Share change
- +786,707
- Total reported value
- $28,477,666
- Put/Call ratio
- 6.7%
- Price per share
- $3.79
- Number of holders
- 57
- Value change
- +$2,854,596
- Number of buys
- 34
- Number of sells
- 11
Report period
Q1 2025
Institutions
57
Top holders
10
DMAC full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Leon G. Cooperman |
13F
|
Individual |
3.1%
|
1,625,000
|
$8,823,750 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
1,242,107
|
$6,744,641 | — | 31 Dec 2024 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
1.6%
|
839,081
|
$4,556,210 | — | 31 Dec 2024 | |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE |
13F
|
Company |
0.98%
|
514,784
|
$2,795,277 | — | 31 Dec 2024 | |
| Bleichroeder LP |
13F
|
Company |
0.73%
|
382,317
|
$2,075,981 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.72%
|
374,845
|
$2,035,408 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
305,751
|
$1,660,614 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
180,192
|
$978,442 | — | 31 Dec 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.29%
|
152,000
|
$825,360 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.21%
|
107,880
|
$585,789 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.18%
|
94,769
|
$514,596 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
87,429
|
$474,739 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
85,029
|
$461,707 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
84,829
|
$460,621 | — | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.15%
|
76,116
|
$413,310 | — | 31 Dec 2024 | |
| Blue Trust, Inc. |
13F
|
Company |
0.13%
|
69,122
|
$375,332 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
68,948
|
$374,388 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
42,212
|
$229,212 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
38,474
|
$208,914 | — | 31 Dec 2024 | |
| CATALYST FINANCIAL PARTNERS LLC |
13F
|
Company |
0.07%
|
38,457
|
$208,822 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
27,726
|
$150,552 | — | 31 Dec 2024 | |
| Meridian Wealth Management, LLC |
13F
|
Company |
0.05%
|
27,216
|
$147,783 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.05%
|
26,097
|
$141,706 | — | 31 Dec 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.05%
|
26,000
|
$141,180 | — | 31 Dec 2024 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.04%
|
22,500
|
$122,175 | — | 31 Dec 2024 | |
| World Investment Advisors |
13F
|
Company |
0.04%
|
21,915
|
$118,999 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
19,339
|
$105,011 | — | 31 Dec 2024 | |
| Stonebridge Capital Advisors LLC |
13F
|
Company |
0.03%
|
17,500
|
$95,025 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.03%
|
16,800
|
$91,224 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
16,113
|
$87,494 | — | 31 Dec 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
15,560
|
$84,491 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.03%
|
15,267
|
$82,900 | — | 31 Dec 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.03%
|
14,973
|
$81,303 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.03%
|
14,581
|
$79,175 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
13,251
|
$71,953 | — | 31 Dec 2024 | |
| MAGNOLIA CAPITAL ADVISORS LLC |
13F
|
Company |
0.02%
|
10,160
|
$55,169 | — | 31 Dec 2024 | |
| MassMutual Private Wealth & Trust, FSB |
13F
|
Company |
0.01%
|
4,824
|
$26,194 | — | 31 Dec 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0.01%
|
4,335
|
$23,539 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,769
|
$9,606 | — | 31 Dec 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
1,070
|
$5,799 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,055
|
$5,729 | — | 31 Dec 2024 | |
| Legend Financial Advisors, Inc. |
13F
|
Company |
0%
|
1,000
|
$5,430 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
330
|
$2,000 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
209
|
$1,135 | — | 31 Dec 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
80
|
$485 | — | 31 Dec 2024 | |
| Amy L. Burroughs |
3/4/5
|
Director |
—
class O/S missing
|
73,288
|
$205,206 | — | 03 Jan 2023 | |
| Harry W. Alcorn Jr. |
3/4/5
|
SVP, Clinical Operations |
—
class O/S missing
|
43,981
|
$123,147 | — | 15 Sep 2021 | |
| Dominic R. Cundari |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
17,800
mixed-class rows
|
$7,840 | — | 01 Jun 2024 | |
| Masuoka K. Lorianne |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
285,000
|
— | — | 22 Jan 2024 | |
| Kirsten L. Gruis |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
67,000
|
— | — | 01 Jun 2023 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2025
As of 31 Mar 2025,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,514,092 shares.
The largest 10 holders included
COOPERMAN LEON G, VANGUARD GROUP INC, FIRST MANHATTAN CO. LLC., PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Bleichroeder LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and LPL Financial LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
45
Q1 2025 holders
57
Holder diff
12
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.